Alzheimer’s Disease Biomarkers Market to Surpass US$ 1.7 Bn by 2031, Driven by Rising Dementia Prevalence and Advances in Early Diagnosis
The global Alzheimer’s disease biomarkers market is witnessing steady expansion as the prevalence of Alzheimer’s disease and other forms of dementia continues to rise worldwide. Alzheimer’s disease is a progressive and irreversible neurodegenerative disorder that affects memory, cognition, behavior, and functional independence. Biomarkers provide measurable indicators of...
0 Комментарии
0 Поделились